Holocene Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.4M Buy
+185,990
New +$61.1M 0.13% 176
2024
Q4
Sell
-317,979
Closed -$165M 787
2024
Q3
$165M Buy
317,979
+40,778
+15% +$21.8M 0.67% 40
2024
Q2
$150M Sell
277,201
-146,663
-35% -$77.5M 0.63% 48
2024
Q1
$220M Buy
+423,864
New +$211M 0.81% 33
2023
Q3
Sell
-207,231
Closed -$92.1M 762
2023
Q2
$92.1M Sell
207,231
-131,914
-39% -$60.9M 0.39% 86
2023
Q1
$156M Buy
339,145
+210,392
+163% +$100M 0.77% 32
2022
Q4
$66M Sell
128,753
-130,871
-50% -$66.4M 0.4% 86
2022
Q3
$118M Buy
259,624
+245,164
+1,695% +$117M 0.75% 42
2022
Q2
$6.98M Sell
14,460
-75,547
-84% -$37.4M 0.04% 285
2022
Q1
$44.2M Buy
+90,007
New +$41.1M 0.23% 134
2021
Q3
Sell
-176,476
Closed -$67.4M 854
2021
Q2
$67.4M Buy
176,476
+110,245
+166% +$42.1M 0.38% 96
2021
Q1
$23.8M Sell
66,231
-190,414
-74% -$61.2M 0.15% 162
2020
Q4
$82.4M Sell
256,645
-151,228
-37% -$46.4M 0.52% 52
2020
Q3
$110M Sell
407,873
-150,039
-27% -$40.4M 0.83% 28
2020
Q2
$147M Buy
557,912
+396,348
+245% +$106M 1.29% 14
2020
Q1
$36.7M Buy
+161,564
New +$44M 0.39% 79
2019
Q3
Sell
-169,460
Closed -$47.8M 744
2019
Q2
$47.8M Buy
169,460
+42,768
+34% +$11.7M 0.61% 63
2019
Q1
$36.4M Sell
126,692
-161,906
-56% -$46.8M 0.56% 60
2018
Q4
$75.8M Buy
288,598
+189,512
+191% +$52.1M 1.22% 25
2018
Q3
$27.2M Buy
99,086
+16,560
+20% +$4.3M 0.44% 75
2018
Q2
$19.6M Buy
+82,526
New +$19.1M 0.42% 73

Other funds holding ELV

Holocene Advisors's ELV Position: Q1 2026 in Review

Holocene Advisors opened a new position in Elevance Health (ELV) in Q1 2026: 185,990 shares worth $54.4M. The stake represents 0.13% of the portfolio and ranks #176 among its holdings. This is a return to the name: Holocene Advisors previously reported a position in ELV as recently as Q3 2024.

Holocene Advisors first reported a position in ELV in Q2 2018 and has held it in 21 quarters since. The position peaked at $220M in Q1 2024. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Holocene Advisors held 185,990 shares of Elevance Health worth $54.4M as of Q1 2026.
  • Elevance Health was a new Holocene Advisors position in Q1 2026.
  • Elevance Health made up 0.13% of Holocene Advisors's portfolio in Q1 2026, its #176 holding.
  • Holocene Advisors first reported a position in Elevance Health in Q2 2018 and has held it in 21 quarters since.
  • Holocene Advisors's Elevance Health position peaked at $220M in Q1 2024.
  • 1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.